DNA-Testing Company 23andMe – What Went Wrong

WSJ explains what went wrong with Wojcicki’s biotech business bringing DNA company 23AndMe from $6B valuation to Penny stock.


This DigitalRosh item or Service is intended for DigitalRosh members

If you are not yet a member

Check Pricing & Sign up, and join us.

Special offer for 2024
Sign up to DigitalRosh PRO or DigitalRosh PLUS now and get 30 days free! Promo code: GIFT30

If you are a member

Kindly log in first to enjoy this item

Use one-click login

Or log in manually with your email

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .